APH.TO - Aphria Inc.
| Previous Close | 11.63 |
| Open | 11.65 |
| Bid | 11.77 x 0 |
| Ask | 11.85 x 0 |
| Day's Range | 11.44 - 11.88 |
| 52 Week Range | 5.14 - 24.75 |
| Volume | 2,586,584 |
| Avg. Volume | 4,304,982 |
| Market Cap | 2.478B |
| Beta | 4.06 |
| PE Ratio (TTM) | 57.23 |
| EPS (TTM) | 0.21 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 18.28 |
CNW Group•4 days agoAphria Appoints Former Southern Glazer's Executive Joel Toguri as Vice President of Sales
LEAMINGTON, ON , June 15, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced the appointment of Joel Toguri as Vice President of Sales effective on June 18, 2018 . Mr. Toguri joins the Company from Southern Glazer's of Canada ("Southern Glazer's"), where he was Vice President of Sales and Operations since 2013.
- CNW Group•11 days ago
Aphria Welcomes Passage of Bill C-45 in Senate, Ready to Meet Demand for Adult-Use Cannabis in Canada
Vic Neufeld , CEO of Aphria, said, "Today's passage of Bill C-45 through the Senate is a historic milestone towards safe and legal recreational cannabis in Canada . "While we share the government's goal to create a highly regulated market, we want to ensure that the cannabis industry is well positioned to responsibly meet the needs of Canadians and effectively compete with the black market, which is operating and marketing unbound by ethical or regulatory considerations.
- Reuters•11 days ago
CANADA STOCKS-TSX lower as financials, energy stocks weigh
Canada's main stock index slipped on Friday, weighed down by financial stocks and the energy sector, as the specter of a trade war loomed ahead of a Group of Seven summit in Quebec. * At 9:34 a.m. ET (1334 GMT), the Toronto Stock Exchange's S&P/TSX Composite index was down 24.49 points, or 0.15 percent, at 16,168.29. * The head of Bank of Canada said on Thursday that trade uncertainty feels more risky than it did in April.
- CNW Group•12 days ago
IIROC Trade Resumption - SMU.UN; PL; ZYME; APH; NVU.UN
IIROC Trade Resumption - SMU.UN; PL; ZYME; APH; NVU.UN
- GlobeNewswire•13 days ago
Aphria Announces $225 Million Bought Deal
Aphria Inc. (“Aphria” or the “Company”) (APH.TO) is pleased to announce that it has entered into an agreement with Clarus Securities Inc., on behalf of a syndicate of underwriters (collectively, the “Underwriters”), pursuant to which the Underwriters have agreed to purchase, on a “bought deal” basis, 18,987,400 Common Shares (the “Common Shares”) of the Company at a price of C$11.85 per Common Share (the “Offering Price”) for aggregate gross proceeds to the Company of C$225,000,690 (the “Offering”).
- Reuters•13 days ago
CANADA STOCKS - TSX rises 0.38 percent, helped by materials
* The Toronto Stock Exchange's S&P/TSX rose 61.68 points, or 0.38 percent, to 16,183.93 points. * The biggest contributor to the TSX gain was Nutrien and materials was the top sector contributor, up 1.7 ...
- CNW Group•13 days ago
Aphria to build state-of-the art Extraction Centre of Excellence
LEAMINGTON, ON , June 6, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced that the company's Board of Directors approved a $55 million capital project to build a state-of-the-art Extraction Centre of Excellence in Leamington, ON . Construction of the new Extraction Centre of Excellence is expected to begin immediately and the facility is scheduled to release its first concentrates by March 2019 . Vic Neufeld , CEO of Aphria, said, "The Extraction Centre of Excellence will give Aphria a significant competitive advantage in cannabis concentrates, which are expected to be a significant product category.
- ACCESSWIRE•14 days ago
Today's Research Reports on Resverlogix, Aphria, IMV and Oncolytics Biotech
NEW YORK, NY / ACCESSWIRE / June 5, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with ...
Oilprice.com•21 days ago5 Companies Using Tech To Transform The Cannabis Industry
As Canada prepares to fully legalize recreational marijuana, several companies are harnessing the tremendous power of technology to completely transform the entire industry, earning millions in the process
- CNW Group•22 days ago
Aphria Forms Landmark Venture with South African Company Verve Group of Companies
The Venture will focus on expanding the Company's footprint in established regulated cannabis markets in Africa . LEAMINGTON, ON , May 28, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced that it has entered into a series of agreements (the "Transaction") resulting in Aphria forming a joint venture, CannInvest Africa Ltd. ("CannInvest"), with South African company Verve Group of Companies ("VGC").
- Reuters•last month
CANADA STOCKS-TSX flat as health stocks offset losses in financials
Canada's main stock index was trading flat on Friday as a rise in healthcare stocks offset a drop in financial shares after inflation data lifted expectations the central bank will hold interest rates ...
- Reuters•last month
PRESS DIGEST- Canada - May 18
The following are the top stories from selected Canadian newspapers. Reuters has not verified these stories and does not vouch for their accuracy. THE GLOBE AND MAIL ** Walmart Inc has reached an agreement ...
- CNW Group•last month
Aphria's German subsidiary, Nuuvera Deutschland, acquires interest in Berlin-based Shöneberg Hospital
LEAMINGTON, ON , May 17, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced that its wholly-owned subsidiary Nuuvera Deutschland GmbH ("Deutschland") has acquired a 25.1% interest in Berlin -based Schöneberg Hospital ("Schöneberg" or the "Hospital"). The acquisition facilitates Deutschland's long-term strategy to educate German physicians and patients and advance evidence that supports the effectiveness of medical cannabinoids.
- CNW Group•last month
Aphria selects Great North Distributors, a Canadian subsidiary of Southern Glazer's Wine & Spirits, for Canada-wide distribution of adult-use cannabis
LEAMINGTON , ON and TORONTO , May 17, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) and Great North Distributors, Inc. ("Great North Distributors"), a wholly-owned Canadian subsidiary of Southern Glazer's Wine & Spirits ("Southern Glazer's") dedicated to the representation of cannabis products, are pleased to announce today that they have signed an agreement for Great North Distributors to serve as exclusive manufacturer's representative for Aphria's adult-use cannabis products throughout Canada , following the legalization of recreational cannabis for adult-use anticipated later this year.
- Business Wire•last month
Aphria Selects Great North Distributors, a Canadian Subsidiary of Southern Glazer’s Wine & Spirits, for Canada-Wide Distribution of Adult-Use Cannabis
Aphria Inc. (“Aphria” or the “Company”) (TSX: APH and US OTC: APHQF) and Great North Distributors, Inc. (“Great North Distributors”), a wholly-owned Canadian subsidiary of Southern Glazer’s Wine & Spirits (“Southern Glazer’s”) dedicated to the representation of cannabis products, are pleased to announce today that they have signed an agreement for Great North Distributors to serve as exclusive manufacturer’s representative for Aphria’s adult-use cannabis products throughout Canada, following the legalization of recreational cannabis for adult-use anticipated later this year.
- Reuters•last month
CANADA STOCKS - TSX rises 0.06 pct, boosted by industrials
* The Toronto Stock Exchange's S&P/TSX rose 10.25 points, or 0.06 percent, to 16,108.06. * The biggest contributor to the TSX gain was Canadian National Railway with 13.3 net index points. The industrials ...
- GlobeNewswire•last month
Scythian Biosciences Announces ColCanna SAS’ Receipt of Licence to Cultivate and Import CBD into Colombia
Scythian Biosciences Corp. (the "Company" or “Scythian”) (SCYB.V) (9SB.F) (OTC – Nasdaq Intl:SCCYF) is pleased to announce that Colombian-based ColCanna SAS (“ColCanna”), a company that Scythian is in the process of acquiring, has received a licence for the cultivation and importation of non-psychoactive cannabis (“CBD”) by the Ministry of Justice and Law of Colombia. Additionally, ColCanna has entered into an exclusive international supply agreement for Colombia (the “Supply Agreement”) with Aphria Inc. (APH.TO) (“Aphria”), a prominent Canadian low-cost producer of medical cannabis.
- CNW Group•last month
Aphria signs exclusive agreement with Colombia-based Colcanna SAS to supply medical cannabis in Colombia
LEAMINGTON , ON, May 16, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced that it has signed an exclusive supply agreement with Colcanna SAS ("Colcanna") a Colombia -based pharmaceutical import and distribution company, which is licensed to import, sell and distribute medical cannabis, medical products and derivatives in Colombia . "We see tremendous potential for medical cannabis in several emerging markets, including Colombia ," said Vic Neufeld , CEO of Aphria.
- Reuters•last month
CANADA STOCKS - TSX rises 0.08 pct, extends winning streak
* The Toronto Stock Exchange's S&P/TSX rose 12.20 points, or 0.08 percent, to 16,097.81. * The biggest contributor to the TSX gain was Canadian National Railway Co, with 10.1 net index points. Industrials ...
- Reuters•last month
CANADA STOCKS - TSX rises on financials boost
* The Toronto Stock Exchange's S&P/TSX rose 79.23 points, or 0.50 percent, to 15,808.63. * The biggest contributor to the TSX gain was Royal Bank of Canada with 9.76 net index points. Financials were the ...
- ACCESSWIRE•2 months ago
Today’s Research Reports on Oncolytics Biotech, CardioComm Solutions, BELLUS Health and Aphria
NEW YORK, NY / ACCESSWIRE / May 4, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with ...
- GlobeNewswire•2 months ago
Scythian Biosciences Corp. Announces the Appointment of European Cannabis Leader Rob Reid of Prohibition Partners as CEO
Scythian Biosciences Corp. (the "Company" or “Scythian”) (SCYB.V) (9SB.F) (OTC – Nasdaq Intl:SCCYF) announced today that it has appointed Rob Reid as CEO, George Scorsis as Chairman of the Board of Directors and that it has reinstated Roger Rai to the Board of Directors effective April 25, 2018. In connection with these appointments, Jonathan Gilbert will be stepping down as CEO and will take on a new role of managing the University of Miami partnership. “I am extremely excited to be appointed as CEO of Scythian,” said Rob Reid.
- CNW Group•2 months ago
Aphria Appoints Chief Commercial Officer and Chief Legal Officer Adding Depth to Leadership Team and Implements New Governance Initiatives
LEAMINGTON, ON , April 25, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced the appointment of Jakob Ripshtein as the Company's first Chief Commercial Officer as of May 1, 2018 and Christelle Gedeon as Chief Legal Officer as of June 1, 2018 . The Company is also announcing several new management appointments as Aphria continues to add depth, experience and leadership across the organization, together with the adoption of a formal governance policy regarding investments and other opportunities.
- CNW Group•2 months ago
Aphria completes first medical cannabis shipment to Australia-based partner Althea
Aphria completes first medical cannabis shipment to Australia-based partner Althea